Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    nitrosyl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cleveland Team: Nitric Oxide Rewires Genes in Alzheimer's Disease
    Cleveland Team: Nitric Oxide Rewires Genes in Alzheimer's Disease

    21 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7467735

    FIRSTWORD PHARMA
    21 May 2026
    Share Share
    Vast Therapeutics Presents Phase 1 ALX1 Data at ATS 2026
    Vast Therapeutics Presents Phase 1 ALX1 Data at ATS 2026

    18 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260518177586/en/Vast-Therapeutics-Presents-Late-Breaking-Phase-1-Data-for-Inhaled-Therapy-ALX1-at-ATS-2026

    BUSINESSWIRE
    18 May 2026
    Share Share
    Vast Therapeutics Presents Phase 1 ALX1 Data at ATS 2026
    Vast Therapeutics Presents Phase 1 ALX1 Data at ATS 2026

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512866253/en/Vast-Therapeutics-to-Present-Phase-1-Data-on-First-in-Class-Nitric-Oxide-Therapy-ALX1-at-the-American-Thoracic-Society-2026-International-Conference

    BUSINESSWIRE
    12 May 2026
    Share Share
    Rhamnan Sulfate's Unique Role In Glycocalyx Support
    Rhamnan Sulfate's Unique Role In Glycocalyx Support

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3271114/0/en/The-Science-Behind-Glycocalyx-Support-Why-Rhamnan-Sulfate-Is-Different.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Beyond Air Expands LungFit PH Access via Top 3 GPO Deal
    Beyond Air Expands LungFit PH Access via Top 3 GPO Deal

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266697/0/en/Beyond-Air-Expands-Commercial-Access-for-LungFit-PH-Through-a-Purchasing-Agreement-with-a-Top-3-National-Group-Purchasing-Organization-GPO.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Beyond Cancer Shows Positive Early Results In Phase 1 UNO Trial
    Beyond Cancer Shows Positive Early Results In Phase 1 UNO Trial

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257691/0/en/Beyond-Cancer-Reports-Early-Clinical-Activity-and-Favorable-Safety-Profile-with-Interim-Data-from-Phase-1-UNO-Trial.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.